At Insight Vision Center Optometry, we offer all four proven myopia management modalities and present them as equal options. There is no single treatment that works best for everyone. The right choice depends on your child's age, maturity level, lifestyle, prescription, and your family's preferences. Our goal is to help you make an informed decision.
Myopia, also called nearsightedness, tends to worsen during childhood as the eyeball grows longer than normal. All four proven treatments work to slow this elongation. By reducing how much the eye grows, these treatments lower your child's final prescription and reduce their lifetime risk of eye disease.
Each treatment has been validated through clinical research and shows significant effectiveness in slowing myopia progression.
The best treatment is the one your child will actually use consistently. A treatment with slightly lower clinical efficacy that your child wears every day provides better real-world results than a treatment with higher efficacy that your child resists or uses inconsistently.
Both Stellest eyeglass lenses and MiSight 1 Day contact lenses have earned FDA authorization specifically for slowing myopia progression in children. This authorization represents years of clinical trials demonstrating both safety and efficacy.
Clinical studies show both treatments provide meaningful protection. Stellest lenses demonstrate approximately 67% reduction in myopia progression over two years based on 10 to 12 hours of daily wear. MiSight contact lenses demonstrate approximately 59% reduction in progression over three years with consistent daily wear. Both treatments offer comparable protection, and the choice between them should be based on lifestyle considerations rather than efficacy alone.
Stellest requires putting on glasses in the morning, wearing them throughout the day, and simple cleaning. There are no special hygiene protocols beyond basic cleanliness. MiSight requires thorough handwashing before handling lenses, daily insertion each morning, proper technique to avoid touching the eye, careful removal each evening, and managing lens supply inventory. Daily lenses are disposed of each night, so no cleaning or storage is needed.
Stellest works well for children as young as 6 years old, kids who are not ready for contact lens responsibility, and families seeking the simplest treatment approach. MiSight works well for children 8 years and older, kids who can follow multi-step hygiene routines, children motivated to handle contacts independently, and kids who strongly prefer not wearing glasses.
Both options work for active children. Stellest offers impact-resistant material suitable for most activities and can be worn with sports straps or protective goggles. MiSight provides unobstructed peripheral vision without frames, eliminates worry about glasses breaking during contact sports, and is preferred by many young athletes for unrestricted movement.
Orthokeratology, often called ortho-k, uses specially designed rigid contact lenses worn during sleep. These lenses gently reshape the cornea overnight. In the morning, the child removes the lenses and enjoys clear vision throughout the day without any glasses or contacts. The effect is temporary, so lenses must be worn every night to maintain clear daytime vision.
Studies suggest orthokeratology provides approximately 36% to 56% reduction in myopia progression. Stellest demonstrates approximately 67% reduction. However, the choice between them rarely comes down to efficacy alone. Lifestyle fit often matters more.
With Stellest, children wear glasses during all waking hours, follow a simple cleaning routine, and sleep without anything on or in their eyes. With orthokeratology, children insert rigid lenses at bedtime, sleep with lenses in place, remove and clean lenses upon waking, and then enjoy complete daytime freedom from vision correction.
Stellest is often preferred by families seeking treatment simplicity, children comfortable wearing glasses, and kids who prefer not having anything in their eyes. Orthokeratology is often preferred by competitive athletes, especially swimmers, children who strongly resist wearing glasses, and families comfortable with nightly lens routines.
Stellest compliance involves remembering to wear glasses throughout the day, keeping track of glasses at school and activities, and basic cleaning. Parent supervision is minimal after initial habit formation. Orthokeratology compliance involves nightly lens insertion and removal, consistent sleep schedules, meticulous cleaning with specific solutions, and more frequent monitoring visits. Parents typically need to supervise more closely, especially at first.
Low-dose atropine eye drops represent a pharmacological approach to myopia management. At very low concentrations, typically 0.01% to 0.05%, atropine effectively slows myopia progression with minimal side effects. This medication has been used in eye care for many decades and has extensive safety data.
Studies suggest low-dose atropine provides approximately 50% to 60% reduction in myopia progression depending on concentration. Stellest demonstrates approximately 67% reduction. However, these treatments work through completely different mechanisms and serve different purposes.
Stellest provides vision correction plus myopia control in one solution. Atropine requires separate glasses for vision correction plus drops for myopia control. Stellest has no medication-related side effects. Low-dose atropine at 0.01% may cause mild light sensitivity in some children, though this increases with higher concentrations.
Atropine is often chosen for very young children under age 6 who are not yet ready for optical treatments. It also works well for children who cannot wear glasses consistently, for combination therapy when a single treatment is not providing enough control, and for pre-myopic children at very high risk of developing myopia.
For children with very rapid progression or those at extremely high risk of developing high myopia, combining treatments may provide additional protection. Combination therapy aims to address myopia progression through multiple mechanisms at once.
Your eye doctor may recommend pairing treatments for maximum benefit.
Your eye doctor will discuss whether combination therapy makes sense based on your child's progression rate, age, and individual risk factors. Not every child needs combination therapy, and many do very well with a single treatment approach.
Your initial treatment choice does not lock you into one path forever. As your child grows and circumstances change, treatments can be adjusted.
Many families make changes over time based on their child's development and preferences.
Regular monitoring visits allow your eye doctor to assess treatment effectiveness and recommend adjustments. Using the Zeiss AXL WAVE Optical Biometer, we can precisely track axial length changes and ensure your child's treatment is working. Our children's vision symptom checker can also help you identify early signs that may warrant a visit.
Consider your child's age and maturity level. Think about whether they are comfortable wearing glasses or tend to resist them. Assess whether they can handle multi-step hygiene routines responsibly. Consider what sports and activities they participate in and whether they have sensory sensitivities that affect their tolerance for glasses or contacts.
Think about what level of daily supervision you can realistically provide. Consider how important treatment simplicity is versus other factors. Factor in your child's schedule, including travel or irregular routines. Consider whether younger siblings might interfere with lens care routines.
Consider whether maximum efficacy is your top priority or whether lifestyle fit matters equally. Think about how rapidly your child's myopia is progressing and what their current prescription and risk level are. Discuss with your eye doctor whether you might need combination therapy if single treatment is not sufficient.
Unlike practices that offer only one or two myopia management options, Insight Vision Center Optometry provides access to all four proven modalities. This means our recommendations are truly individualized based on your child's needs rather than limited by what we happen to offer.
Our team includes Dr. Thanh Mai, OD, FSLS, FIAOMC, who serves as VP of Clinical Innovation for Treehouse Eyes and sits on the EssilorLuxottica advisory board for Stellest. Dr. Nathan Schramm, OD, FSLS, FBCLA served as principal investigator for the Euclid Phoenix ortho-k trial. Dr. Ariel Chen, OD is a co-investigator on that same trial and manages ortho-k and atropine protocols. Dr. Valerie Lam, OD, FAAO, FOVDR brings pediatric vision and vision therapy integration when needed. Dr. Nhi Nguyen, OD has Treehouse Eyes affiliation and ortho-k experience.
We do not rank treatments or push you toward one option. We provide thorough education about each treatment's benefits and considerations, help you understand your child's specific situation, and support whatever decision you make. If circumstances change and a different treatment becomes more appropriate, we have the experience to transition smoothly.
We use the Zeiss AXL WAVE Optical Biometer and Pentacam for precise axial length tracking and corneal imaging. This technology helps us monitor your child's progress accurately and adjust treatment when needed.
Most children continue treatment until their late teens when eye growth naturally slows. The typical treatment period runs from diagnosis, often between ages 6 and 12, through ages 18 to 20. Your eye doctor will monitor your child's eye growth and recommend when treatment can be gradually reduced or stopped.
Yes, treatment choices are not permanent. If your child struggles with contact lens compliance, they can switch to glasses, and if glasses become impractical for sports, they can try contacts or ortho-k. We monitor progress at every visit and can adjust the approach as needed.
Without treatment, childhood myopia typically continues to worsen until the late teens or early twenties. Higher levels of myopia increase the lifetime risk of serious eye conditions including retinal detachment, glaucoma, cataracts, and myopic maculopathy. Treatment aims to reduce the final prescription and lower these long-term risks.
Stellest lenses have no known side effects beyond those of regular glasses. MiSight and orthokeratology carry the same risks as other contact lenses, primarily related to hygiene and proper wear schedules. Low-dose atropine may cause mild light sensitivity in some children, though this is less common at lower concentrations. Your eye doctor will discuss specific risks for each option.
We track your child's progress using axial length measurements, which show how much the eyeball is growing. We also monitor prescription changes. Successful treatment shows slower progression compared to what would be expected without intervention. We review these measurements at regular monitoring visits.
Low-dose atropine can be used for children as young as 3 or 4 years old in some cases. Stellest is appropriate for children as young as 6. If your child is diagnosed early and is not ready for other treatments, we can start with atropine and add optical treatments when they are developmentally ready.
